A mild Knoevenagel coupling reaction between an indol-2-thione and a ribofuranose derivative was developed for the synthesis of 2-benzylthio-5,6-dichloro-3-(β-D-ribofuranosyl)indole (12). 3-(β-D-ribofuranosyl)-2,5,6-trichloroindole (16) was prepared from 12 in 4 steps. A Lewis acid-mediated glycosylation method was then developed to prepare the targeted 2-haloindole C-nucleoside 16 stereoselectively
2,5,6-Trichloro-1-(β-D-ribofuranosyl)benzimidazole (TCRB), 2-bromo-5,6-dichloro-1-(β-D-ribofuranosyl)benzimidazole (BDCRB) 和 2-benzylthio- 5,6-二
氯-1-(β-D-
呋喃核糖基)
苯并咪唑 (BTDCRB) 是
苯并咪唑核苷,具有强大的选择性抗 HCMV 活性。多卤化
吲哚 C-核苷制备为
苯并咪唑核苷 TCRB 和 BDCRB 的 1-脱氮类似物。开发了 indol-2-thione 和 ribofuranose 衍
生物之间的温和 Knoevenagel 偶联反应,用于合成 2-benzylthio-5,6-dichloro-3-(β-D-ribofuranosyl) indole (12)。3-(β-D-
呋喃核糖基)-2,5,6-三
氯吲哚 (16) 由 12